Using tumor cells cultured in vitro, we reported that doxorubicin inhibited proliferation of cells expressing CREB3L1 but not those in which the gene was not expressed, even though the drug was equally effective in triggering DNA damage in both cells [5]. Here, CREB3L1 is linked to neoplasm.